Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.02
-0.13 (-2.43%)
At close: Aug 15, 2025, 3:59 PM
5.07
1.00%
After-hours: Aug 15, 2025, 05:10 PM EDT

Foghorn Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.94M -18.83M -19.5M -19.12M -22.98M -25.02M -24.11M -14.35M -29.49M -30.49M -28.89M -25.77M -27.31M -26.91M -29.14M -26.08M -23.11M -22.99M
Depreciation & Amortization
900K 827K 761K 733K 800K 835K 852K 864K 876K 859K 848K 843K 819K 811K 810K 861K 784K 772K
Stock-Based Compensation
2.73M 2.69M 2.48M 3.02M 3.17M 3.22M 3.05M 4.09M 4.47M 4.57M 3.78M 3.8M 3.51M 3.24M 2.08M 2.37M 2.04M 1.89M
Other Working Capital
-6.97M -9.57M -8.45M -3.88M -8.83M -8.62M -8M -18.06M -8.42M -8.24M 293.67M -316K -4.49M -8.03M 35.67M 708K 125K -3.2M
Other Non-Cash Items
3.76M 631K -141K -400K 8.73M 6.39M 5.89M 1.32M 1.29M 430K 1.5M -168K 1.14M 1.15M 1.15M 1.12M 1.19M 1.15M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -4.99M -652K -731K n/a n/a n/a n/a n/a 1.33M 100K -5K -13K
Change in Working Capital
-7.72M -9.28M -8.12M -5.23M -9.66M -9.25M -8.24M -18.5M -8.59M -6.55M -6.17M 1.31M -6.83M 293.24M 35.65M 1.12M 620K -3.96M
Operating Cash Flow
-21M -23.97M -24.52M -21M -25.54M -29.34M -27.54M -27.21M -32.17M -31.18M -28.92M -19.99M -29.01M 271.53M 11.88M -20.5M -18.48M -23.15M
Capital Expenditures
-22K -28K -479K -309K -17K -101K -37K -82K -469K -636K -269K -330K -364K -247K -80K -230K -1.21M -1.79M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -1K 1K -39.6M n/a 6.24M -46.38M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-42.14M -51.12M -39.65M -124.45M -66.1M -31.26M -6.84M -3.86M -36.97M -26.23M -44.34M -9.62M -143.09M -212.29M -10.25M -47.1M -16.17M -26.47M
Sales Maturities Of Investments
76M 80.55M 62.42M 63.45M 48.15M 58.46M 44.26M 42.37M 76.57M 56.37M 38.1M 56M 19M 53.13M 20M n/a 94.47M 25M
Other Investing Acitivies
n/a n/a n/a n/a -17.96M 27.2M 37.42M 38.51M 39.6M n/a -6.24M 46.38M -124.09M -159.16M 9.75M -47.1M 78.3M -1.47M
Investing Cash Flow
33.83M 29.4M 22.29M -61.31M -17.98M 27.09M 37.38M 38.43M 39.13M 29.5M -6.51M 46.05M -124.46M -159.41M 9.67M -47.33M 77.09M -3.26M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.45M -390K 103.21M 1.17M 186K 1.39M 103K 102K 16K 333K 1.03M 384K 21.74M 505K 111K 62K
Financial Cash Flow
254K 139K 4K 1.05M 103.21M 1.17M 186K 1.39M 103K 102K 16K 333K 1.03M 384K 21.74M 505K 111K 62K
Net Cash Flow
12.8M 5.57M -2.22M -81.27M 59.69M -1.08M 10.03M 12.6M 7.06M -1.57M -35.41M 26.4M -152.44M 112.51M 43.3M -67.33M 58.72M -26.35M
Free Cash Flow
-21.02M -24M -25M -21.31M -25.55M -29.45M -27.58M -27.29M -32.64M -31.82M -29.19M -20.32M -29.38M 271.29M 11.8M -20.73M -19.69M -24.94M